Clinical Trial Update: The Real-world Study of Rimegepant Treatment in Female Migraine Patients of China

View source ↗

Summary

Real-world study evaluating rimegepant treatment in female migraine patients in China; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Migraine, Migraine Prophylaxis | Status: NOT_YET_RECRUITING